Suppression	O
and	O
re	O
-	O
expression	O
of	O
transformed	O
phenotype	O
in	O
hybrids	B-Cell
of	O
HA	O
-	O
ras	O
-	O
1	O
-	O
transformed	O
rat	B-Cell
-	I-Cell
1	I-Cell
cells	I-Cell
and	O
early	O
-	O
passage	O
rat	O
embryonic	B-Cell
fibroblasts	I-Cell
.	O

Rat	B-Cell
-	I-Cell
1	I-Cell
cells	I-Cell
which	O
had	O
been	O
transformed	O
with	O
the	O
activated	O
Ha	O
-	O
ras	O
-	O
1	O
gene	O
from	O
human	O
EJ	B-Cell
bladder	I-Cell
carcinoma	I-Cell
cells	I-Cell
were	O
fused	O
with	O
diploid	O
embryonic	B-Cell
rat	I-Cell
fibroblasts	I-Cell
.	O

Four	O
selected	O
cell	B-Cell
hybrids	I-Cell
expressed	O
the	O
human	O
transforming	O
gene	O
product	O
p21	O
at	O
levels	O
of	O
10	O
to	O
30	O
%	O
compared	O
to	O
100	O
%	O
in	O
the	O
transformed	O
parental	O
cells	B-Cell
.	O

The	O
hybrid	B-Cell
cells	I-Cell
,	O
however	O
,	O
exhibited	O
normal	O
morphology	O
,	O
anchorage	O
requirement	O
for	O
proliferation	O
,	O
and	O
largely	O
extended	O
latency	O
periods	O
of	O
tumorigenicity	O
in	O
newborn	O
rats	O
.	O

Tumorigenic	O
hybrid	B-Cell
derivatives	I-Cell
contained	O
lower	O
numbers	O
of	O
chromosomes	B-Cellular_component
than	O
the	O
tetraploid	O
parental	B-Cell
hybrids	I-Cell
.	O

DNA	O
of	O
the	O
non	O
-	O
tumorigenic	O
cell	B-Cell
hybrids	I-Cell
transformed	O
Rat	B-Cell
-	I-Cell
1	I-Cell
cells	I-Cell
to	O
anchorage	O
-	O
independent	O
proliferation	O
as	O
expected	O
for	O
the	O
transforming	O
human	O
Ha	O
-	O
ras	O
gene	O
present	O
in	O
the	O
donor	O
DNA	O
.	O

We	O
conclude	O
that	O
the	O
transforming	O
properties	O
of	O
the	O
activated	O
Ha	O
-	O
ras	O
gene	O
in	O
Rat	B-Cell
-	I-Cell
1	I-Cell
cells	I-Cell
can	O
be	O
suppressed	O
at	O
the	O
post	O
-	O
translational	O
level	O
by	O
the	O
presence	O
of	O
the	O
genome	O
from	O
diploid	O
embryonic	B-Cell
rat	I-Cell
fibroblasts	I-Cell
but	O
additional	O
controls	O
of	O
expression	O
of	O
the	O
transforming	O
gene	O
are	O
likely	O
to	O
exist	O
.	O

Normal	O
cells	B-Cell
contain	O
suppressor	O
gene	O
(	O
s	O
)	O
which	O
safeguard	O
these	O
cells	B-Cell
against	O
transformation	O
by	O
the	O
product	O
of	O
the	O
transforming	O
Ha	O
-	O
ras	O
-	O
1	O
oncogene	O
.	O

